DYN in the 13F filings
Dyne Therapeutics Inc · CUSIP 26818M108
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 26
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 5 listed it in both
- Shares listed
- 29,074,845
- combined, among listed positions
- Reported value
- $569m
- combined, at the quarter end
Among the 92 comparable managers: 15 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -4,084,568.
Managers listing DYN in Q4 2025
26 of 26 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 6,569,921 shares now+1,168,005
- T. Rowe Price Associates Incexisting position · 2,323,789 shares now+925,702
- Artisan Partners LPnew position · 649,691 shares now+649,691
- Millennium Management LLCexisting position · 904,389 shares now+490,449
- Balyasny Asset Management LLCnew position · 432,986 shares now+432,986
Reductions
- Marshall Wace LLPexisting position · 676,979 shares now-2,336,398
- Citadel Advisors LLCexisting position · 1,171,624 shares now-2,241,811
- Point72 Asset Management LPexisting position · 329,345 shares now-1,388,462
- Janus Henderson Group Ltdexisting position · 13,887,722 shares now-857,783
- Jane Street Group LLCexisting position · 70,323 shares now-211,017
New positions and exits
New (6)
Exited (4)
- Voloridge Investment Management LLCwas $9.0m
- Schonfeld Strategic Advisors LLCwas $5.3m
- D. E. Shaw & Co.was $526k
- Quantbot Technologies LPwas $222k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2020 | 3 | $11m | n.a. | n.a. |
| Q4 2020 | 1 | $10m | n.a. | n.a. |
| Q1 2021 | 1 | $5.9m | n.a. | n.a. |
| Q2 2021 | 2 | $19m | n.a. | n.a. |
| Q3 2021 | 2 | $17m | n.a. | n.a. |
| Q4 2021 | 2 | $21m | n.a. | n.a. |
| Q1 2022 | 2 | $26m | n.a. | n.a. |
| Q2 2022 | 1 | $4.6m | n.a. | n.a. |
| Q3 2022 | 1 | $19m | n.a. | n.a. |
| Q4 2022 | 2 | $17m | n.a. | n.a. |
| Q1 2023 | 1 | $432k | n.a. | n.a. |
| Q2 2023 | 1 | $4.3m | n.a. | n.a. |
| Q3 2023 | 1 | $3.0m | n.a. | n.a. |
| Q4 2023 | 1 | $5.8m | 1 | 0 |
| Q1 2024 | 4 | $123m | 3 | 1 |
| Q2 2024 | 5 | $433m | 5 | 0 |
| Q3 2024 | 5 | $392m | 3 | 2 |
| Q4 2024 | 6 | $287m | 4 | 2 |
| Q1 2025 | 5 | $141m | 4 | 2 |
| Q2 2025 | 3 | $94m | 1 | 1 |
| Q3 2025 | 5 | $228m | 3 | 1 |
| Q4 2025 | 5 | $291m | 15 | 14 |
| Q1 2026 | 5 | $264m | 13 | 14 |
| Q2 2026 | 3 | $288m | 12 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
DYN and LLY →DYN and JNJ →DYN and VRTX →Choose a stock to compare with DYN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own DYN, latest filings →Back to the 13F Explorer →